PROCEPT BioRobotics (PRCT) reported second-quarter 2026 revenue of $94.5 million, up 19% from the prior-year period, driven by higher U.S. handpiece and system revenue and international revenue.
The surgical robotics company reported a second-quarter net loss of $26.9 million, compared with a loss of $19.6 million a year earlier. PROCEPT reiterated full-year 2026 revenue guidance of $390 million to $410 million.
- Total revenue: $94.5 million, up 19% year over year.
- U.S. revenue: $83.4 million, up 20% from the prior-year period.
- International revenue: $11.1 million, up 15% year over year.
- Net loss: $26.9 million, versus $19.6 million in the prior-year period.
- Gross margin: 66%, compared with 65% a year earlier.
- Guidance: Full-year 2026 revenue expected at $390 million to $410 million, with U.S. procedure volume expected at 54,000 to 56,000.
$PRCT Insider Trading Activity
$PRCT insiders have traded $PRCT stock on the open market 16 times in the past 6 months. Of those trades, 7 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PRCT stock by insiders over the last 6 months:
- ANTAL ROHIT DESAI has made 7 purchases buying 426,262 shares for an estimated $10,482,942 and 0 sales.
- ALALEH NOURI (EVP, CLO, CORP. SEC.) has made 0 purchases and 5 sales selling 12,844 shares for an estimated $319,259.
- KEVIN WATERS (EVP, CFO) has made 0 purchases and 3 sales selling 7,784 shares for an estimated $189,343.
- BARRY L TEMPLIN (EVP, Chief Technology Officer) sold 358 shares for an estimated $10,195
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$PRCT Hedge Fund Activity
We have seen 118 institutional investors add shares of $PRCT stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. removed 3,238,095 shares (-95.6%) from their portfolio in Q1 2026, for an estimated $80,984,755
- FMR LLC removed 3,191,207 shares (-68.6%) from their portfolio in Q1 2026, for an estimated $79,812,087
- ARROWMARK COLORADO HOLDINGS LLC removed 1,349,831 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $33,759,273
- POINT72 ASSET MANAGEMENT, L.P. added 1,128,543 shares (+inf%) to their portfolio in Q1 2026, for an estimated $28,224,860
- DIVISADERO STREET CAPITAL MANAGEMENT, LP added 866,338 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,667,113
- WELLINGTON MANAGEMENT GROUP LLP added 861,605 shares (+inf%) to their portfolio in Q1 2026, for an estimated $21,548,741
- MIROVA added 723,842 shares (+inf%) to their portfolio in Q1 2026, for an estimated $18,103,288
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
